|
1
|
Howell A, Anderson AS, Clarke RB, Duffy
SW, Evans DG, Garcia-Closas M, Gescher AJ, Key TJ, Saxton JM and
Harvie MN: Risk determination and prevention of breast cancer.
Breast Cancer Res. 16:4462014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Gray JM, Rasanayagam S, Engel C and Rizzo
J: State of the evidence 2017: An update on the connection between
breast cancer and the environment. Environ Health. 16:942017.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ward R, Sims AH, Lee A, Lo C, Wynne L,
Yusuf H, Gregson H, Lisanti MP, Sotgia F, Landberg G and Lamb R:
Monocytes and macrophages, implications for breast cancer migration
and stem cell-like activity and treatment. Oncotarget.
6:14687–14699. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Need EF, Selth LA, Trotta AP, Leach DA,
Giorgio L, O'Loughlin MA, Smith E, Gill PG, Ingman WV, Graham JD
and Buchanan G: The unique transcriptional response produced by
concurrent estrogen and progesterone treatment in breast cancer
cells results in upregulation of growth factor pathways and
switching from a luminal a to a basal-like subtype. BMC Cancer.
15:7912015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Bodai BI and Tuso P: Breast cancer
survivorship: A comprehensive review of long-term medical issues
and lifestyle recommendations. Perm J. 19:48–79. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Lages E, Ipas H, Guttin A, Nesr H, Berger
F and Issartel JP: MicroRNAs: Molecular features and role in
cancer. Front Biosci (Landmark Ed). 17:2508–2540. 2012. View Article : Google Scholar
|
|
7
|
Greene SB, Herschkowitz JI and Rosen JM:
Small players with big roles: MicroRNAs as targets to inhibit
breast cancer progression. Curr Drug Targets. 11:1059–1073. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zhu X, Li D, Yu F, Jia C, Xie J, Ma Y, Fan
S, Cai H, Luo Q, Lv Z and Fan L: miR-194 inhibits the
proliferation, invasion, migration, and enhances the
chemosensitivity of non-small cell lung cancer cells by targeting
forkhead box A1 protein. Oncotarget. 7:13139–13152. 2016.PubMed/NCBI
|
|
9
|
Okato A, Arai T, Yamada Y, Sugawara S,
Koshizuka K, Fujimura L, Kurozumi A, Kato M, Kojima S, Naya Y, et
al: Dual strands of pre-miR-149 inhibit cancer cell migration and
invasion through targeting FOXM1 in renal cell carcinoma. Int J Mol
Sci. 18:E19692017. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Dell'Aversana C, Giorgio C, D'Amato L,
Lania G, Matarese F, Saeed S, Di Costanzo A, Belsito Petrizzi V,
Ingenito C, Martens JHA, et al: miR-1945p/BCLAF1 deregulation in
AML tumorigenesis. Leukemia. 31:2315–2325. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Chang HY, Ye SP, Pan SL, Lania G, Matarese
F, Saeed S, Di Costanzo A, Belsito Petrizzi V, Ingenito C, Martens
JHA, et al: Overexpression of miR-194 reverses HMGA2-driven
signatures in colorectal cancer. Theranostics. 7:3889–3900. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Hironaka-Mitsuhashi A, Matsuzaki J,
Takahashi RU, Yoshida M, Nezu Y, Yamamoto Y, Shiino S, Kinoshita T,
Ushijima T, Hiraoka N, et al: A tissue microRNA signature that
predicts the prognosis of breast cancer in young women. PLoS One.
12:e01876382017. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Ring A, Kim YM and Kahn M: Wnt/catenin
signaling in adult stem cell physiology and disease. Stem Cell Rev.
10:512–525. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Lien WH and Fuchs E: Wnt some lose some:
Transcriptional governance of stem cells by Wnt/β-catenin
signaling. Genes Dev. 28:1517–1532. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Aminuddin A and Ng PY: Promising druggable
target in head and neck squamous cell carcinoma: Wnt signaling.
Front Pharmacol. 7:2442016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Yin D, Jia Y, Yu Y, Brock MV, Herman JG,
Han C, Su X, Liu Y and Guo M: SOX17 methylation inhibits its
antagonism of Wnt signaling pathway in lung cancer. Discov Med.
14:33–40. 2012.PubMed/NCBI
|
|
17
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
18
|
Huo D, Clayton WM, Yoshimatsu TF, Chen J
and Olopade OI: Identification of a circulating microRNA signature
to distinguish recurrence in breast cancer patients. Oncotarget.
7:55231–55248. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Jung KH, McCarthy RL, Zhou C, Uprety N,
Barton MC and Beretta L: MicroRNA regulates hepatocytic
differentiation of progenitor cells by targeting YAP1. Stem Cells.
34:1284–1296. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Liu X, Luo M, Xie W, Wells JM, Goodheart
MJ and Engelhardt JF: Sox17 modulates Wnt3A/beta-catenin-mediated
transcriptional activation of the Lef-1 promoter. Am J Physiol Lung
Cell Mol Physiol. 299:L694–L710. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Yang H, Lee S, Lee S, Kim K, Yang Y, Kim
JH, Adams RH, Wells JM, Morrison SJ, Koh GY and Kim I: Sox17
promotes tumor angiogenesis and destabilizes tumor vessels in mice.
J Clin Invest. 123:418–431. 2013. View
Article : Google Scholar :
|
|
22
|
Lv Li, He ZY, Wang G, Zhang J, Lu X, Ren
G, Wang X, Zhu F, Ding XY, et al: The SOX17/miR-3715p/SOX2 axis
inhibits EMT, stem cell properties and metastasis in colorectal
cancer. Oncotarget. 6:9099–9112. 2015.
|
|
23
|
Guimarães-Young A, Neff T, Dupuy AJ and
Goodheart MJ: Conditional deletion of Sox17 reveals complex effects
on uterine adenogenesis and function. Dev Biol. 414:219–227. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Gao L, Chen B, Li J, Yang F, Cen X, Liao Z
and Long X: Wnt/β-catenin signaling pathway inhibits the
proliferation and apoptosis of U87 glioma cells via different
mechanisms. PLoS One. 12:e01813462017. View Article : Google Scholar
|
|
25
|
Lisanti MP, Tsirigos A, Pavlides S, Reeves
KJ, Peiris-Pagès M, Chadwick AL, Sanchez-Alvarez R, Lamb R, Howell
A, Martinez-Outschoorn UE and Sotgia F: JNK1 stress signaling is
hyper-activated in high breast density and the tumor stroma:
Connecting fibrosis, inflammation, and stemness for cancer
prevention. Cell Cycle. 13:580–599. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Jang GB, Kim JY, Cho SD, Park KS, Jung JY,
Lee HY, Hong IS and Nam JS: Blockade of Wnt/β-catenin signaling
suppresses breast cancer metastasis by inhibiting CSC-like
phenotype. Sci Rep. 5:124652015. View Article : Google Scholar
|
|
27
|
Dey N, Barwick BG, Moreno CS,
Ordanic-Kodani M, Chen Z, Oprea-Ilies G, Tang W, Catzavelos C,
Kerstann KF, Sledge GW Jr, et al: Wnt signaling in triple negative
breast cancer is associated with metastasis. BMC Cancer.
13:5372013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Liu T, Hu K, Zhao Z, Chen G, Ou X, Zhang
H, Zhang X, Wei X, Wang D, Cui M and Liu C: MicroRNA-1
down-regulates proliferation and migration of breast cancer stem
cells by inhibiting the Wnt/β-catenin pathway. Oncotarget.
6:41638–41649. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Yin X, Xiang T, Li L, Su X, Shu X, Luo X,
Huang J, Yuan Y, Peng W, Oberst M, et al: DACT1, an antagonist to
Wnt/β-catenin signaling, suppresses tumor cell growth and is
frequently silenced in breast cancer. Breast Cancer Res.
15:R232013. View
Article : Google Scholar
|
|
30
|
Fu D, Ren C, Tan H, Wei J, Zhu Y, He C,
Shao W and Zhang J: Sox17 promoter methylation in plasma DNA is
associated with poor survival and can be used as a prognostic
factor in breast cancer. Medicine (Baltimore). 94:e6372015.
View Article : Google Scholar
|
|
31
|
Manavalan TT, Teng Y, Litchfield LM,
Muluhngwi P, Al-Rayyan N and Klinge CM: Reduced expression of
miR-200 family members contributes to antiestrogen resistance in
LY2 human breast cancer cells. PLoS One. 8:e623342013. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Zhang G, Zhang W, Li B, Stringer-Reasor E,
Chu C, Sun L, Bae S, Chen D, Wei S, Jiao K, et al: MicroRNA-200c
and microRNA- 141 are regulated by a FOXP3-KAT2B axis and
associated with tumor metastasis in breast cancer. Breast Cancer
Res. 19:732017. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Peng Y, Zhang X, Feng X, Fan X and Jin Z:
The crosstalk between microRNAs and the Wnt/β-catenin signaling
pathway in cancer. Oncotarget. 8:14089–14106. 2017.
|
|
34
|
Jia Y, Yang Y, Zhan Q, Brock MV, Zheng X,
Yu Y, Herman JG and Guo M: Inhibition of SOX17 by microRNA 141 and
methylation activates the WNT signaling pathway in esophageal
cancer. J Mol Diagn. 14:577–585. 2012. View Article : Google Scholar : PubMed/NCBI
|
